| Closure of patent foramen ovale versus medical therapy after cryptogenic stroke JD Carroll, JL Saver, DE Thaler, RW Smalling, S Berry, LA MacDonald, ... New England Journal of Medicine 368 (12), 1092-1100, 2013 | 1112 | 2013 |
| Long-term outcomes of patent foramen ovale closure or medical therapy after stroke JL Saver, JD Carroll, DE Thaler, RW Smalling, LA MacDonald, DS Marks, ... New England Journal of Medicine 377 (11), 1022-1032, 2017 | 1024 | 2017 |
| Spontaneous coronary artery dissection: current state of the science: a scientific statement from the American Heart Association SN Hayes, ESH Kim, J Saw, D Adlam, C Arslanian-Engoren, KE Economy, ... Circulation 137 (19), e523-e557, 2018 | 939 | 2018 |
| An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke DM Kent, R Ruthazer, C Weimar, JL Mas, J Serena, S Homma, ... Neurology 81 (7), 619-625, 2013 | 629 | 2013 |
| Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? AA Alsheikh-Ali, DE Thaler, DM Kent Stroke 40 (7), 2349-2355, 2009 | 455 | 2009 |
| Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke C Sánchez-Moreno, JF Dashe, T Scott, D Thaler, MF Folstein, A Martin Stroke 35 (1), 163-168, 2004 | 286 | 2004 |
| Cervical arterial dissections and association with cervical manipulative therapy: a statement for healthcare professionals from the American Heart Association/American Stroke … J Biller, RL Sacco, FC Albuquerque, BM Demaerschalk, P Fayad, ... Stroke 45 (10), 3155-3174, 2014 | 236 | 2014 |
| Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (amulet IDE): a randomized, controlled trial D Lakkireddy, D Thaler, CR Ellis, V Swarup, L Sondergaard, J Carroll, ... Circulation 144 (19), 1543-1552, 2021 | 234 | 2021 |
| Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials DM Kent, IJ Dahabreh, R Ruthazer, AJ Furlan, M Reisman, JD Carroll, ... Journal of the American College of Cardiology 67 (8), 907-917, 2016 | 232 | 2016 |
| The functions of the medial premotor cortex: I. Simple learned movements D Thaler, YC Chen, PD Nixon, CE Stern, RE Passingham Experimental Brain Research 102, 445-460, 1995 | 213 | 1995 |
| Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Genomic and Precision Medicine; and Stroke Council. Spontaneous coronary artery … SN Hayes, ESH Kim, J Saw, D Adlam, C Arslanian-Engoren, KE Economy, ... Circulation 137 (19), e523-e557, 2018 | 188 | 2018 |
| Management strategies for asymptomatic carotid stenosis: a systematic review and meta-analysis G Raman, D Moorthy, N Hadar, IJ Dahabreh, TF O'Donnell, DE Thaler, ... Annals of internal medicine 158 (9), 676-685, 2013 | 188 | 2013 |
| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 181 | 2018 |
| Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence GD Kitsios, IJ Dahabreh, AM Abu Dabrh, DE Thaler, DM Kent Stroke 43 (2), 422-431, 2012 | 175 | 2012 |
| Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale–associated stroke AY Elgendy, JL Saver, Z Amin, KD Boudoulas, JD Carroll, IY Elgendy, ... JAMA neurology 77 (7), 878-886, 2020 | 137 | 2020 |
| The functions of the medial premotor cortex: II. The timing and selection of learned movements YC Chen, D Thaler, PD Nixon, CE Stern, RE Passingham Experimental Brain Research 102, 461-473, 1995 | 130 | 1995 |
| Recurrent stroke predictors differ in medically treated patients with pathogenic vs other PFOs DE Thaler, R Ruthazer, C Weimar, JL Mas, J Serena, E Di Angelantonio, ... Neurology 83 (3), 221-226, 2014 | 129 | 2014 |
| The Risk of Paradoxical Embolism (RoPE) Study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic … DM Kent, DE Thaler, RoPE Study Investigators Trials 12, 1-9, 2011 | 125 | 2011 |
| Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis DM Kent, IJ Dahabreh, R Ruthazer, AJ Furlan, C Weimar, J Serena, ... European heart journal 36 (35), 2381-2389, 2015 | 122 | 2015 |
| Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke DM Kent, JL Saver, SE Kasner, J Nelson, JD Carroll, G Chatellier, ... Jama 326 (22), 2277-2286, 2021 | 116 | 2021 |
